Want to join the conversation?
$OREX 2Q15 PR: Revenue was $5.2MM, including $3.1MM in royalties earned on US net sales of Contrave of $16MM recorded by Takeda Pharmaceuticals. Net loss was $22.5MM, or $0.18 per share vs. net loss of $24.5MM, or $0.21 per share for 2Q14.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.